Category: 13104-56-8

Some tips on 13104-56-8

13104-56-8, As the paragraph descriping shows that 13104-56-8 is playing an increasingly important role.

13104-56-8, 4′-(4-Methoxyphenyl)-2,2′:6′,2”-terpyridine is a catalyst-ligand compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

A mixture of Ni(NO3)2.6H2O (0.070g, 0.24 mmol), meophtpy(0.078 g, 0.023 mmol) and NaClO4 (0.028 g, 0.023 mmol) inacetonitrile (30 mL) was sonicated for 10min. The resulted clearsolution was left alone until many brown crystals were obtained.Yield: 0.005g, 44.7%. Calcd. For C44H38Cl2N6NiO12 (1): C, 56.61;H, 4.17; N, 10.60%. Found: C, 56.76; H, 4.11; N, 10.67%. IR(KBr,cm1): 3066.82(w), 1600.92(vs), 1519.91(s), 1473.61(s), 1435.04(s), 1367.53(s), 1240.23(s), 1192.01(m), 1087.85(vs), 1024.20(s), 829.39(s), 794.67(vs), 729.09(m), 657.72(m), 621.08(m), 584.43(m), 518.85(m), 418.55(m).

13104-56-8, As the paragraph descriping shows that 13104-56-8 is playing an increasingly important role.

Reference£º
Article; Fu, Wei-Wei; Shen, Jing-Run; Tang, Zi-Qing; Peng, Yong-Qiong; Yi, Qing; Inorganic and Nano-Metal Chemistry; vol. 47; 12; (2017); p. 1664 – 1667;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

Simple exploration of 13104-56-8

As the paragraph descriping shows that 13104-56-8 is playing an increasingly important role.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.13104-56-8,4′-(4-Methoxyphenyl)-2,2′:6′,2”-terpyridine,as a common compound, the synthetic route is as follows.

Co(NO3)2*6H2O (67 mg, 0.24 mmol), meophtpy (78 mg, 0.23 mmol), and NaClO4 (67.2 mg, 48 mmol) were dissolved in 30 ml of CH3CN. A few drops of water were added until the solution became clear. A crop of purple crystals was obtained in two weeks., 13104-56-8

As the paragraph descriping shows that 13104-56-8 is playing an increasingly important role.

Reference£º
Article; Fu; Shu; Luo; Tang; Li; Liu; Cheng; Wang; Liu; Journal of Structural Chemistry; vol. 59; 2; (2018); p. 398 – 410; Zh. Strukt. Khim.; vol. 59; 2; (2018); p. 412 – 424,13;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

Brief introduction of 13104-56-8

13104-56-8 4′-(4-Methoxyphenyl)-2,2′:6′,2”-terpyridine 630929, acatalyst-ligand compound, is more and more widely used in various.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.13104-56-8,4′-(4-Methoxyphenyl)-2,2′:6′,2”-terpyridine,as a common compound, the synthetic route is as follows.

General procedure: IrCl3 (0.0299g, 0.1mmol) was mixed with 3-MeO-Phtpy, 2-MeO-Phtpy or 4-MeO-Phtpy (0.0339g, 0.1mmol), 0.20mL DMSO and 0.50mL CH3OH in a Pyrex tube. The Pyrex tube containing the reaction mixture was then placed in liquid N2, vacuumed and sealed. The reaction was initiated by heating the reaction mixture to 80C. After two days of incubation at 80C, the resulting brown-black crystals were isolated and characterized by different spectroscopic and analytic techniques.

13104-56-8 4′-(4-Methoxyphenyl)-2,2′:6′,2”-terpyridine 630929, acatalyst-ligand compound, is more and more widely used in various.

Reference£º
Article; Qin, Qi-Pin; Meng, Ting; Tan, Ming-Xiong; Liu, Yan-Cheng; Luo, Xu-Jian; Zou, Bi-Qun; Liang, Hong; European Journal of Medicinal Chemistry; vol. 143; (2018); p. 1387 – 1395;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI